GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Well Lead Medical Co Ltd (SHSE:603309) » Definitions » Cyclically Adjusted FCF per Share

Well Lead Medical Co (SHSE:603309) Cyclically Adjusted FCF per Share : ¥0.20 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Well Lead Medical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Well Lead Medical Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.119. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.20 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Well Lead Medical Co's average Cyclically Adjusted FCF Growth Rate was -28.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-05-01), Well Lead Medical Co's current stock price is ¥12.30. Well Lead Medical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.20. Well Lead Medical Co's Cyclically Adjusted Price-to-FCF of today is 61.50.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Well Lead Medical Co was 69.68. The lowest was 47.56. And the median was 60.35.


Well Lead Medical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Well Lead Medical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Well Lead Medical Co Cyclically Adjusted FCF per Share Chart

Well Lead Medical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.21

Well Lead Medical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.25 0.22 0.21 0.20

Competitive Comparison of Well Lead Medical Co's Cyclically Adjusted FCF per Share

For the Medical Instruments & Supplies subindustry, Well Lead Medical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Well Lead Medical Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Well Lead Medical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Well Lead Medical Co's Cyclically Adjusted Price-to-FCF falls into.



Well Lead Medical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Well Lead Medical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.119/114.6694*114.6694
=-0.119

Current CPI (Mar. 2024) = 114.6694.

Well Lead Medical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.126 98.200 0.147
201409 0.067 98.900 0.078
201412 0.141 99.000 0.163
201503 0.037 99.900 0.042
201506 -0.016 99.500 -0.018
201509 0.025 100.500 0.029
201512 0.147 100.600 0.168
201603 -0.048 102.200 -0.054
201606 0.003 101.400 0.003
201609 -0.002 102.400 -0.002
201612 0.118 102.600 0.132
201703 -0.078 103.200 -0.087
201706 0.063 103.100 0.070
201709 -0.009 104.100 -0.010
201712 0.047 104.500 0.052
201803 -0.095 105.300 -0.103
201806 0.095 104.900 0.104
201809 -0.071 106.600 -0.076
201812 0.134 106.500 0.144
201903 -0.022 107.700 -0.023
201906 0.093 107.700 0.099
201909 0.096 109.800 0.100
201912 0.096 111.200 0.099
202003 0.017 112.300 0.017
202006 0.205 110.400 0.213
202009 0.144 111.700 0.148
202012 0.150 111.500 0.154
202103 -0.092 112.662 -0.094
202106 0.161 111.769 0.165
202109 -0.011 112.215 -0.011
202112 0.252 113.108 0.255
202203 -0.047 114.335 -0.047
202206 0.341 114.558 0.341
202209 0.223 115.339 0.222
202212 0.205 115.116 0.204
202303 0.003 115.116 0.003
202306 -0.187 114.558 -0.187
202309 -0.290 115.339 -0.288
202312 0.014 114.669 0.014
202403 -0.119 114.669 -0.119

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Well Lead Medical Co  (SHSE:603309) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Well Lead Medical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=12.30/0.2
=61.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Well Lead Medical Co was 69.68. The lowest was 47.56. And the median was 60.35.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Well Lead Medical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Well Lead Medical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Well Lead Medical Co (SHSE:603309) Business Description

Traded in Other Exchanges
N/A
Address
No. 45-47, South of Guomao Avenue, No. 4, Area C, Jinhu Industrial City, Hualong Town, Panyu District, Guangdong Province, Guangzhou City, CHN, 511434
Well Lead Medical Co Ltd is engaged in research, production, and sales of medical catheters in anaesthesia, urology, respiratory and hemodialysis region. Its products include Endotracheal Tube, Standar Endotracheal Tube, and Suction Endotracheal Tube. The company products are used in surgery, treatment, first aid, and nursing. The company exports its products to North America, Europe, and Japan.

Well Lead Medical Co (SHSE:603309) Headlines

No Headlines